|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Pain, Postoperative | |||||
| 2 | More general conditions related to this trial | ||||
| Pain | |||||
| Pathologic Processes | |||||
| Postoperative Complications | |||||
| Signs and Symptoms | |||||
| 3 | Interventions listed in this trial | ||||
| Gabapentin group | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Gabapentin | |||||
| 5 | More general drug interventions related to this trial | ||||
| Analgesics | |||||
| Anti-Anxiety Agents | |||||
| Anti-Dyskinesia Agents | |||||
| Anticonvulsants | |||||
| Antimanic Agents | |||||
| Antiparkinson Agents | |||||
| Calcium Channel Blockers | |||||
| Cardiovascular Agents | |||||
| Central Nervous System Agents | |||||
| Central Nervous System Depressants | |||||
| Excitatory Amino Acid Agents | |||||
| Excitatory Amino Acid Antagonists | |||||
| Membrane Transport Modulators | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Psychotropic Drugs | |||||
| Sensory System Agents | |||||
| Therapeutic Uses | |||||
| Tranquilizing Agents | |||||
| 6 | Sponsors listed in this trial | ||||
| Aarhus University Hospital | |||||